TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
AMRN

Amarin Corporation PLC

Healthcare · Drug Manufacturers - General

12.30$ -3.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Amarin Corporation PLC (AMRN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 42 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AMRN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
66 75 57 68 42 62 42 73 50 49 45 42 186
36 30 25 26 26 72 17 22 27 27 27 27 109
30 45 32 42 16 -9.6 25 50 22 22 18 15 77
5.1 5.8 5.6 4.0 4.5 6.0 5.3 4.9 4.2 4.7 4.7 4.8 18
21 21 19 18 18 17 20 24 14 16 17 19 67
51 50 45 43 41 43 42 66 33 25 26 27 111
-21 -4.8 -14 -0.5 -25 -53 -17 -16 -11 -2.3 -8.0 -12 -33
– 0.0 – – – 0.0 – – – 0.0 – – –
-19 -2.4 -8.7 2.9 -22 -50 -14 -13 -8.1 -0.9 -8.7 -7.9 -26
0.5 3.3 1.3 1.4 3.6 -1.3 2.1 0.7 -0.4 0.4 1.8 -0.2 1.6
-19 -5.8 -10.0 1.5 -25 -49 -16 -14 -7.7 -1.2 -11 -7.7 -27
-20 -0.9 -7.9 3.7 -21 -37 -13 7.5 -0.8 -0.1 -7.4 -11 -20

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?